Biomarker Discordances and Alterations Observed in Breast Cancer Treated with Neoadjuvant Chemotherapy: Causes, Frequencies, and Clinical Significances

Purpose: Biomarker discordances and alterations can be encountered between tru-cut biopsy and residual tumor in breast cancer treated with neoadjuvant chemotherapy (NACTx). We aimed to investigate the effect of NACTx on major biomarker expression (ER, PR, HER2, Ki-67) and tumor grade, the frequency...

Descripción completa

Detalles Bibliográficos
Autores principales: Yilmaz, Cengiz, Cavdar, Demet Kocatepe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776827/
https://www.ncbi.nlm.nih.gov/pubmed/36547175
http://dx.doi.org/10.3390/curroncol29120761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776827/
https://www.ncbi.nlm.nih.gov/pubmed/36547175
http://dx.doi.org/10.3390/curroncol29120761

Ejemplares similares